All Industries

Top Life Sciences Companies

416 Life Sciences companies, sorted by total funding raised.

PharvarisIPO

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for ...

Zug, Switzerland51–200Biotech, Healthcare
Private Equity·$216.0M·Jun 2023
Satellite Bio

Develops off-the-shelf liver cell therapies that deliver functional hepatocytes to restore liver ...

Cambridge, United States11–50Biotech, Life Sciences
Series B·$215.5M·Jan 2024
DP Technology

Develops AI-for-Science platforms and tools to accelerate scientific discovery for researchers an...

Beijing, China201–500Computational Biology, Drug Discovery
Series C·$213.7M·Dec 2025
CANbridgeIPO

CANbridge is a biotechnology company focused on developing and commercializing rare disease thera...

Burlington, China201–500Life Sciences, Biotech
Series E·$211.0M·Dec 2020
Autobahn Therapeutics

Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychiatric and n...

San Diego, United States11–50Life Sciences
Series C·$208.7M·Jul 2024
SchrödingerIPO

Physics-based computational platform for molecular design that helps pharmaceutical, biotechnolog...

New York, United States501–1000Artificial Intelligence, Biotech
Grant·$205.0M·Jul 2024
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Venture Round·$200.0M·Dec 2025
HarmonyCares

Provides physician-led, value-based in-home primary care and ancillary services for medically com...

Troy, United States1001–5000Life Sciences, Healthcare
Growth Equity·$200.0M·Jul 2024
CinCor PharmaAcquired

CinCor Pharma is a clinical-stage biopharmaceutical company with a mission to bring innovation to...

United States1–10Life Sciences
Series B·$193.0M·Oct 2021
Cellanome

Biotechnology company developing an automated platform for multimodal single-cell analysis, enabl...

Foster City, United States51–200Biotech, Lab Equipment
Series B·$192.8M·Jan 2024
Fabric

Fabric is a healthcare technology company offering an AI-powered care enablement platform that un...

New York, United States201–500Artificial Intelligence, Healthcare
Series A·$190.0M·Feb 2024
TScan TherapeuticsIPO

Clinical-stage biotechnology company developing T cell receptor (TCR)-engineered T cell therapies...

Waltham, United States51–200Biotech, Healthcare
Corporate Round·$190.0M·Dec 2024
10x GenomicsIPO

Biotechnology company providing single-cell genomics analysis tools

Pleasanton, United States1001–5000Biotech, Life Sciences
Series D·$187.6M·Apr 2018
Watershed Informatics

Cloud platform for omics data analysis and collaboration, serving biopharma and research teams to...

Cambridge, United States11–50Bioinformatics, Healthcare
Series C·$184.5M·Feb 2024
Genome Medical

Telehealth genetic counseling and test-support for patients, providers, and life-sciences partner...

South San Francisco, United States51–200Digital Health, Genomics
Series D·$183.3M·Oct 2024
Caribou BiosciencesIPO

Clinical-stage biopharmaceutical company developing genome-edited allogeneic CAR-T cell therapies...

Berkeley, United States51–200Biotech, Healthcare
Corporate Round·$181.0M·Jul 2023
AdageneIPO

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies wit...

Suzhou, China51–200Artificial Intelligence, Biotech
Corporate Round·$180.0M·Jul 2025
VectorY

VectorY is on a mission to provide patients with neurodegenerative diseases a longer, better life...

Amsterdam, Netherlands51–200Life Sciences
Series A·$175.6M·Nov 2023
Ironwood PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing therapies for gastrointestinal diseases ...

Boston, United States201–500Biotech, Healthcare
Corporate Round·$175.0M·Feb 2019
Variant Bio

Genomic drug discovery company developing therapies by studying people with exceptional health-re...

Seattle, United States11–50Life Sciences
Corporate Round·$171.0M·Jan 2025
AviadoBio

AviadoBio is a biotechnology company developing transformative gene therapies for neurodegenerati...

London, United Kingdom51–200Biotech, Genomics
Series B·$168.5M·Apr 2025
Vizgen

Life sciences company developing spatial biology and multi-omics platforms to map gene and protei...

Cambridge, United States51–200Biotech, Life Sciences
Series C·$158.2M·Jun 2022
Third Harmonic BioIPO

Third Harmonic Bio is a clinical stage biotechnology company developing an oral KIT inhibitor the...

Boston, United StatesLife Sciences
Series B·$155.0M·Dec 2021
EpizymeIPO

Biopharmaceutical company that is creating innovative drugs for major diseases based on important...

Cambridge, United States201–500Biotech, Drug Discovery
Growth Equity·$154.0M·Nov 2019
SciNeuro

SciNeuro is a clinical-stage biotechnology company that develops innovative medicines for patient...

Shanghai, ChinaLife Sciences
Series B·$153.0M·Dec 2025